Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

Abstract

A segmental genomic profile, rather than the single genetic markers, adds prognostic information to the clinical markers age and stage in neuroblastoma patients without MNA, underlining the importance of pangenomic studies.